Extended-Release Trazodone Tablets Approved

2/4/2010
The FDA has approved Labopharm’s Oleptro (trazodone hydrochloride) extended-release tablets for the once-daily treatment of major depressive disorder in adults. The company expects to begin marketing the product sometime later this year.
Clin-eguide™ is an online clinical decision support tool that provides the most accurate evidence-based information for health care providers in the clinical setting. It integrates trusted content from Ovid, Facts & Comparisons®, and Lippincott Williams and Wilkins, as well as other premier publishers.